Theresa Fukuda, PA
Medical · Boston, MANPI 1366006330
Payments from drug & device makers
Across 674 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Arcutis Biotherapeutics, Inc.$1K
- Lilly USA, LLC$953
- Sanofi$929
- plus $5K from 19 others
What the payments were for
- Food & beverage$11,70093%
- Education$9217%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 153 | $2,284 |
| Johnson & Johnson | 76 | $1,752 |
| Regeneron Healthcare Solutions, Inc. | 43 | $1,089 |
| Arcutis Biotherapeutics, Inc. | 80 | $1,046 |
| Lilly USA, LLC | 48 | $953 |
| Sanofi | 59 | $929 |
| Galderma Laboratories, L.p. | 49 | $847 |
| UCB, Inc. | 41 | $824 |
| Novartis | 29 | $431 |
| E.r. Squibb & Sons, L.L.C. | 19 | $411 |
| LEO Pharma Inc. | 14 | $365 |
| Sun Pharmaceutical Industries Inc. | 10 | $297 |
| Sanofi-aventis U.S. LLC | 3 | $251 |
| Incyte Corporation | 12 | $209 |
| Pfizer | 7 | $160 |
| Amgen | 6 | $139 |
| Organon | 6 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $120 |
| Boehringer Ingelheim | 3 | $79 |
| Dermavant Sciences, Inc. | 4 | $77 |
| VYNE Pharmaceuticals Inc. | 3 | $75 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $46 |
| Biofrontera Inc. | 2 | $45 |
| Mission Pharmacal Company | 3 | $44 |
| Bristol Myers Squibb | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,621 in reported general payments places this provider in the 95th percentile of 421 medical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $51,360 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 13 | $4,023 |
| Ketoconazole | 134 | $2,839 |
| Metronidazole | 54 | $2,204 |
| Betamethasone Dipropionate | 37 | $1,392 |
| Clobetasol Propionate | 25 | $1,345 |
| Triamcinolone Acetonide | 87 | $1,240 |
| Fluorouracil | 17 | $748 |
| Alclometasone Dipropionate | 15 | $744 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 14 | $687 |
| Spironolactone | 19 | $631 |
| Doxycycline Hyclate | 20 | $315 |
| Mometasone Furoate | 11 | $270 |
| Minocycline Hcl | 23 | $270 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 16 | $221 |
Paid to pharmacies, not to this prescriber.
Other medical in Boston
- Elissa HokinsonBoston$6K
- Carrie SepkeBoston$2K
- Donna FitzgeraldBoston$2K
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Christina MessingerPlymouth$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.